Mesoblast Reports Operational and Financial Highlights for Quarter Ended December 31, 2022

… mesenchymal lineage cell therapy technology platform to establish a … -L allogeneic stromal cell technology platforms. Remestemcel-L is … the United States and Singapore and is listed on the … its product candidates and technology; estimates of Mesoblast’s …